PAX8 lineage-driven T cell engaging antibody for the treatment of high-grade serous ovarian cancer

PAX8 lineage-driven T cell engaging antibody for the treatment of high-grade serous ovarian cancer

Abstract High-grade serous ovarian cancers (HGSOC) represent the most common subtype of ovarian malignancies. Due to the frequency of late-stage diagnosis and high rates of recurrence following standard of care treatments, novel therapies are needed to promote durable responses. We investigated the...

সম্পূর্ণ বিবরণ

গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক: Emily Lee, Sarah Szvetecz, Ryan Polli, Angelo Grauel, Jayson Chen, Joyce Judge, Smita Jaiswal, Rie Maeda, Stephanie Schwartz, Bernd Voedisch, Mateusz Piksa, Chietara Japutra, Lingheswar Sadhasivam, Yiqin Wang, Ana Carrion, Sinan Isim, Jinsheng Liang, Thomas Nicholson, Hong Lei, Qing Fang, Michelle Steinkrauss, Dana Walker, Joel Wagner, Viviana Cremasco, Hui Qin Wang, Giorgio G. Galli, Brian Granda, Keith Mansfield, Quincey Simmons, Andrew Anh Nguyen, Nicole Vincent Jordan
বিন্যাস: প্রবন্ধ
ভাষা:English
প্রকাশিত: Nature Portfolio 2021-07-01
মালা:Scientific Reports
অনলাইন ব্যবহার করুন:https://doi.org/10.1038/s41598-021-93992-1

আন্তর্জাল

https://doi.org/10.1038/s41598-021-93992-1

অনুরূপ উপাদানগুলি